Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis

Chemotherapy is often omitted in elderly patients with glioblastoma multiforme due to a fear of side effects. We applied metronomic chemotherapy with low-dose temozolomide and celecoxib (LD-TEM/CEL) during and after external beam radiotherapy (EBRT) and here report on how this regimen compares to st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Welzel, Grit (VerfasserIn) , Brehmer, Stefanie (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Seiz-Rosenhagen, Marcel (VerfasserIn) , Schmiedek, Peter (VerfasserIn) , Wenz, Frederik (VerfasserIn) , Giordano, Frank Anton (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 June 2015
In: Journal of neuro-oncology
Year: 2015, Jahrgang: 124, Heft: 2, Pages: 265-273
ISSN:1573-7373
DOI:10.1007/s11060-015-1834-x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s11060-015-1834-x
Verlag, Volltext: https://link-springer-com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s11060-015-1834-x
Volltext
Verfasserangaben:Grit Welzel, Julian Gehweiler, Stefanie Brehmer, Jens-Uwe Appelt, Andreas von Deimling, Marcel Seiz-Rosenhagen, Peter Schmiedek, Frederik Wenz, Frank A. Giordano

MARC

LEADER 00000caa a2200000 c 4500
001 1570659435
003 DE-627
005 20220814090853.0
007 cr uuu---uuuuu
008 180308s2015 xx |||||o 00| ||eng c
024 7 |a 10.1007/s11060-015-1834-x  |2 doi 
035 |a (DE-627)1570659435 
035 |a (DE-576)500659435 
035 |a (DE-599)BSZ500659435 
035 |a (OCoLC)1340994115 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Welzel, Grit  |d 1969-  |e VerfasserIn  |0 (DE-588)1034853139  |0 (DE-627)74633754X  |0 (DE-576)382474031  |4 aut 
245 1 0 |a Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme  |b a retrospective analysis  |c Grit Welzel, Julian Gehweiler, Stefanie Brehmer, Jens-Uwe Appelt, Andreas von Deimling, Marcel Seiz-Rosenhagen, Peter Schmiedek, Frederik Wenz, Frank A. Giordano 
264 1 |c 5 June 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.03.2018 
520 |a Chemotherapy is often omitted in elderly patients with glioblastoma multiforme due to a fear of side effects. We applied metronomic chemotherapy with low-dose temozolomide and celecoxib (LD-TEM/CEL) during and after external beam radiotherapy (EBRT) and here report on how this regimen compares to standard temozolomide radiochemotherapy (SD-TEM) in elderly patients. We retrospectively analyzed records of 146 patients aged 65 years and older that underwent EBRT. Factors of interest were age, performance status, comorbidities, MGMT status, therapy (resection/biopsy, radiotherapy/dose, chemotherapy/regimen/dose), progression-free (PFS) and overall survival (OS) status. Irrespective of the regimen, addition of chemotherapy more than doubled median survival rates (EBRT only: 4.2 months; EBRT + LD-TEM/CEL: 8.5 months; EBRT + SD-TEM: 10.8 months; p ≤ 0.008). Although patients receiving metronomic LD-TEM/CEL were significantly older (62 % were ≥75 years vs. 22 %; p < 0.001), had significantly lower performance scores (50 % had a KPS <70 vs. 28 %; p = 0.049) and were significantly more comorbid (73 % had ≥4 comorbidities vs. 37 %; p = 0.002) than patients of the SD-TEM group, there were no significant differences in PFS and OS. Independent of other factors, omission of chemotherapy significantly impairs progression-free and overall survival. With all the limitations of a retrospective analysis, our data suggest that metronomic chemotherapy with LD-TEM/CEL may be equieffective and eventually better tolerated than SD-TEM. It may be offered to elderly patients that are not eligible for standard chemotherapy. 
700 1 |a Brehmer, Stefanie  |d 1979-  |e VerfasserIn  |0 (DE-588)102834127X  |0 (DE-627)732703751  |0 (DE-576)375691138  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Seiz-Rosenhagen, Marcel  |d 1977-  |e VerfasserIn  |0 (DE-588)129921807  |0 (DE-627)483655503  |0 (DE-576)297904019  |4 aut 
700 1 |a Schmiedek, Peter  |d 1943-2021  |e VerfasserIn  |0 (DE-588)1059102056  |0 (DE-627)797964045  |0 (DE-576)415128080  |4 aut 
700 1 |a Wenz, Frederik  |d 1966-  |e VerfasserIn  |0 (DE-588)113310390  |0 (DE-627)663837766  |0 (DE-576)346656281  |4 aut 
700 1 |a Giordano, Frank Anton  |d 1980-  |e VerfasserIn  |0 (DE-588)136378455  |0 (DE-627)694333093  |0 (DE-576)300990529  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neuro-oncology  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983  |g 124(2015), 2, Seite 265-273  |h Online-Ressource  |w (DE-627)32046122X  |w (DE-600)2007293-4  |w (DE-576)107058944  |x 1573-7373  |7 nnas  |a Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme a retrospective analysis 
773 1 8 |g volume:124  |g year:2015  |g number:2  |g pages:265-273  |g extent:9  |a Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme a retrospective analysis 
856 4 0 |u http://dx.doi.org/10.1007/s11060-015-1834-x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link-springer-com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s11060-015-1834-x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180308 
993 |a Article 
994 |a 2015 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 136378455  |a Giordano, Frank Anton  |m 136378455:Giordano, Frank Anton  |d 60000  |d 63000  |e 60000PG136378455  |e 63000PG136378455  |k 0/60000/  |k 1/60000/63000/  |p 9  |y j 
998 |g 113310390  |a Wenz, Frederik  |m 113310390:Wenz, Frederik  |d 60000  |d 63000  |e 60000PW113310390  |e 63000PW113310390  |k 0/60000/  |k 1/60000/63000/  |p 8 
998 |g 1059102056  |a Schmiedek, Peter  |m 1059102056:Schmiedek, Peter  |d 60000  |d 62600  |e 60000PS1059102056  |e 62600PS1059102056  |k 0/60000/  |k 1/60000/62600/  |p 7 
998 |g 129921807  |a Seiz-Rosenhagen, Marcel  |m 129921807:Seiz-Rosenhagen, Marcel  |d 60000  |d 62600  |e 60000PS129921807  |e 62600PS129921807  |k 0/60000/  |k 1/60000/62600/  |p 6 
998 |g 102834127X  |a Brehmer, Stefanie  |m 102834127X:Brehmer, Stefanie  |d 60000  |d 62600  |e 60000PB102834127X  |e 62600PB102834127X  |k 0/60000/  |k 1/60000/62600/  |p 3 
998 |g 1034853139  |a Welzel, Grit  |m 1034853139:Welzel, Grit  |d 60000  |d 63000  |e 60000PW1034853139  |e 63000PW1034853139  |k 0/60000/  |k 1/60000/63000/  |p 1  |x j 
999 |a KXP-PPN1570659435  |e 3002137731 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"title":[{"title":"Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme","subtitle":"a retrospective analysis","title_sort":"Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme"}],"relHost":[{"language":["eng"],"note":["Gesehen am 11.06.2018","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1983 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2007293-4"],"eki":["32046122X"],"issn":["1573-7373"]},"recId":"32046122X","origin":[{"publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}],"disp":"Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme a retrospective analysisJournal of neuro-oncology","title":[{"title":"Journal of neuro-oncology","title_sort":"Journal of neuro-oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"124","text":"124(2015), 2, Seite 265-273","extent":"9","issue":"2","year":"2015","pages":"265-273"}}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"5 June 2015"}],"name":{"displayForm":["Grit Welzel, Julian Gehweiler, Stefanie Brehmer, Jens-Uwe Appelt, Andreas von Deimling, Marcel Seiz-Rosenhagen, Peter Schmiedek, Frederik Wenz, Frank A. Giordano"]},"id":{"eki":["1570659435"],"doi":["10.1007/s11060-015-1834-x"]},"recId":"1570659435","type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","family":"Welzel","display":"Welzel, Grit","given":"Grit"},{"given":"Stefanie","family":"Brehmer","role":"aut","display":"Brehmer, Stefanie"},{"role":"aut","family":"Deimling","display":"Deimling, Andreas von","given":"Andreas von"},{"family":"Seiz-Rosenhagen","role":"aut","display":"Seiz-Rosenhagen, Marcel","given":"Marcel"},{"given":"Peter","display":"Schmiedek, Peter","family":"Schmiedek","role":"aut"},{"family":"Wenz","role":"aut","display":"Wenz, Frederik","given":"Frederik"},{"family":"Giordano","role":"aut","display":"Giordano, Frank Anton","given":"Frank Anton"}],"note":["Gesehen am 08.03.2018"],"language":["eng"]} 
SRT |a WELZELGRITMETRONOMIC5201